William Heiden

William Heiden

Chairman bei MACROGENICS, INC.

Vermögen: 251 300 $ am 30.04.2024

64 Jahre
Health Technology
Consumer Services
Miscellaneous

Ursprung des Netzwerks ersten Grades von William Heiden

EinheitArt der EinheitIndustrie
75
Subsidiary Pharmaceuticals: Major 75
Subsidiary Pharmaceuticals: Major 56
Public Company Pharmaceuticals: Major 38
Public Company Pharmaceuticals: Major 19
Subsidiary Biotechnology 16
5
Extinct Investment Trusts/Mutual Funds 5
4
Holding Company Medical Specialties 4
3
Non-Profit Organization Pharmaceuticals: Major 3
2
Subsidiary Biotechnology 2
2
Extinct Pharmaceuticals: Major 2

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von William Heiden

UnternehmenSektorVerknüpfte PersonenHauptposition
AMGEN INC. Pharmaceuticals: Major

Beth Seidenberg

Carol Gallagher

Roy Baynes

Michael Narachi

Joseph Newell

Private Equity Investor

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

Director/Board Member

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Beth Seidenberg

Meenu Chhabra Karson

Karen Ferrante

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Barbara H. Deptula

Thomas Spitznagel

Corporate Officer/Principal

Corporate Officer/Principal

JOHNSON & JOHNSON Pharmaceuticals: Major

Jim Suddendorf

Jay Siegel

Comptroller/Controller/Auditor

Corporate Officer/Principal

ELI LILLY AND COMPANY Pharmaceuticals: Major

Carol Gallagher

Scott Jackson

Stephen Eck

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Beth Seidenberg

Patricia Russo

Richard S. Bowles

Roy Baynes

Paul R. Fonteyne

David Monteith

Nancy Miller-Rich

Private Equity Investor

Director/Board Member

General Counsel

Chief Tech/Sci/R&D Officer

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Carol Gallagher

Karen Ferrante

Julie Krop

Stephen Eck

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

STRYKER CORPORATION Medical Specialties

Frederic Roch Doliveux

Julie Krop

Director/Board Member

Corporate Officer/Principal

BIOGEN INC. Pharmaceuticals: Major

Carol Gallagher

George Scangos

Sales & Marketing

Chief Executive Officer

Pharmaceuticals: Major

George Scangos

Matthew Fust

Director/Board Member

Director of Finance/CFO

SANGAMO THERAPEUTICS, INC. Biotechnology

Margaret Liu

Heather Turner

Director/Board Member

General Counsel

Medical Specialties

Richard A. Moscicki

Geoffrey F. Cox

Marc A. Becker

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Director of Finance/CFO

Pharmaceuticals: Major

Carol Gallagher

George Scangos

Corporate Officer/Principal

Chairman

University of Notre Dame College/University

Scott Jackson

James Karrels

Eric Hyllengren

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Joel Marcus

Geoffrey F. Cox

Frederic Roch Doliveux

Scott Koenig

Michael Narachi

Meenu Chhabra Karson

Anne Phillips

Jeffrey Peters

Jay Siegel

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Director/Board Member

Miscellaneous Commercial Services

Robert Ferdinand van Oordt

Rajiv De Silva

Ameet Mallik

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Stanford University College/University

James Sulat

Isaac E. Ciechanover

James Karrels

Rajiv De Silva

Eric Risser

Maria Grazia Roncarolo

Jay Siegel

Graduate Degree

Undergraduate Degree

Masters Business Admin

Graduate Degree

Masters Business Admin

Corporate Officer/Principal

Doctorate Degree

Investment Managers

Beth Seidenberg

John F. McGrath

Isaac E. Ciechanover

Consultant / Advisor

Corporate Officer/Principal

Private Equity Investor

UCB Pharmaceuticals: Major

Douglas James Gingerella

Frederic Roch Doliveux

Scott Myers

Comptroller/Controller/Auditor

Chief Executive Officer

Corporate Officer/Principal

College/University

Joel Marcus

John Craighead

Director/Board Member

Doctorate Degree

University of Rhode Island College/University

Edward Jordan

Edward Rudnic

Undergraduate Degree

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Joseph Vincent Bonventre

Thomas Spitznagel

Anhco Nguyen

Corporate Officer/Principal

Undergraduate Degree

Corporate Officer/Principal

College/University

Richard A. Moscicki

Bill Athenson

Scott Myers

Ameet Mallik

Undergraduate Degree

Masters Business Admin

Undergraduate Degree

Graduate Degree

Rutgers State University of New Jersey College/University

Donald R. Conklin

Hugh A. D'Andrade

Federica O’Brien

Weiying Yang

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Yale University College/University

James Sulat

Eric Risser

Brian Robinson

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

College/University

Edward Hurwitz

George Scangos

Scott Koenig

Joseph Vincent Bonventre

Christopher S. James

Undergraduate Degree

Director/Board Member

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Princeton University College/University

Eric Dobmeier

Richard S. Bowles

Rajiv De Silva

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

INSEAD College/University

Frederic Roch Doliveux

Pascal Touchon

Masters Business Admin

Masters Business Admin

University of Massachusetts College/University

George Scangos

Marc A. Becker

Doctorate Degree

Undergraduate Degree

GLYCOMIMETICS, INC. Pharmaceuticals: Major

Scott Jackson

Scott Koenig

Director/Board Member

Director/Board Member

APPLIED GENETIC TECHNOLOGIES CORPORATION Pharmaceuticals: Generic

Edward Hurwitz

Scott Koenig

Director/Board Member

Chairman

Georgetown University College/University

Patricia Russo

Karen Ferrante

Robert Blood

Director/Board Member

Doctorate Degree

Undergraduate Degree

General Government

Beth Seidenberg

Scott Koenig

Ezio Bonvini

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Paul R. Fonteyne

Joseph Vittiglio

Corporate Officer/Principal

Director/Board Member

General Government

Richard A. Moscicki

Ezio Bonvini

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Eugene R. McGrath

Patricia Russo

Director/Board Member

Corporate Officer/Principal

Miscellaneous Commercial Services

Joel Marcus

Geoffrey F. Cox

Frank Thomas

Kathryn Carr Payne

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Beth Seidenberg

Margaret Liu

Roy Baynes

Corporate Officer/Principal

Director/Board Member

Chief Tech/Sci/R&D Officer

DECIBEL THERAPEUTICS, INC. Biotechnology

Joseph LaRosa

George Scangos

Corporate Secretary

Chairman

New York University School of Law College/University

Joseph LaRosa

Thomas Haughey

Graduate Degree

Graduate Degree

Tufts University School of Medicine College/University

John Fallon

Brian Robinson

Doctorate Degree

Doctorate Degree

The Wharton School of the University of Pennsylvania College/University

Rajiv De Silva

Ameet Mallik

Masters Business Admin

Masters Business Admin

AKCEA THERAPEUTICS, INC. Pharmaceuticals: Major

Richard A. Moscicki

Michael W. Stevenson

Director/Board Member

Corporate Officer/Principal

Berkeley Law University of California College/University

Edward Hurwitz

Eric Dobmeier

Graduate Degree

Graduate Degree

Biotechnology

Heather Turner

Anne Phillips

Chief Executive Officer

Director/Board Member

Statistik

International

Vereinigte Staaten 48
Frankreich 3
Belgien 2

Sektoral

Health Technology 26
Consumer Services 17
Commercial Services 6
Finance 3
Government 3

Operativ

Director/Board Member 499
Corporate Officer/Principal 253
Independent Dir/Board Member 158
Chief Executive Officer 99
President 91
  1. Börse
  2. Insiders
  3. William Heiden
  4. Unternehmensverbindungen